Ryan Specialty Holdings, Inc. (NYSE:RYAN) Receives Average Rating of “Hold” from Analysts

Ryan Specialty Holdings, Inc. (NYSE:RYANGet Free Report) has been given a consensus recommendation of “Hold” by the twelve ratings firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and six have issued a buy recommendation on the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $73.50.

A number of research analysts have recently issued reports on the stock. Barclays lifted their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a report on Thursday, November 21st. Morgan Stanley assumed coverage on shares of Ryan Specialty in a report on Thursday. They set an “overweight” rating and a $90.00 price target on the stock. Bank of America boosted their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a report on Thursday, October 10th. BMO Capital Markets upgraded shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and boosted their price target for the stock from $65.00 to $75.00 in a report on Tuesday, September 24th. Finally, The Goldman Sachs Group boosted their price target on shares of Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a report on Wednesday, October 9th.

Read Our Latest Research Report on RYAN

Insider Buying and Selling

In related news, Director David P. Bolger sold 7,055 shares of the company’s stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total transaction of $500,058.40. Following the sale, the director now owns 78,149 shares of the company’s stock, valued at approximately $5,539,201.12. This represents a 8.28 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Mark Stephen Katz sold 14,790 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the sale, the executive vice president now directly owns 12,386 shares in the company, valued at $884,236.54. This trade represents a 54.42 % decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Ryan Specialty

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. State Street Corp grew its stake in Ryan Specialty by 1.5% in the 3rd quarter. State Street Corp now owns 3,273,093 shares of the company’s stock worth $217,301,000 after buying an additional 49,198 shares in the last quarter. Janus Henderson Group PLC grew its stake in Ryan Specialty by 0.4% in the 3rd quarter. Janus Henderson Group PLC now owns 3,148,916 shares of the company’s stock worth $209,058,000 after buying an additional 13,986 shares in the last quarter. Blair William & Co. IL grew its stake in Ryan Specialty by 3.4% in the 2nd quarter. Blair William & Co. IL now owns 2,866,003 shares of the company’s stock worth $165,970,000 after buying an additional 94,663 shares in the last quarter. Barclays PLC grew its stake in Ryan Specialty by 1.1% in the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company’s stock worth $108,994,000 after buying an additional 17,267 shares in the last quarter. Finally, Eagle Asset Management Inc. grew its stake in Ryan Specialty by 32.1% in the 3rd quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company’s stock worth $98,555,000 after buying an additional 335,180 shares in the last quarter. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Ryan Specialty Trading Down 1.4 %

RYAN opened at $73.42 on Friday. Ryan Specialty has a 1-year low of $41.49 and a 1-year high of $75.97. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The company has a market cap of $19.22 billion, a P/E ratio of 95.35, a price-to-earnings-growth ratio of 1.68 and a beta of 0.67. The company has a fifty day moving average price of $70.71 and a two-hundred day moving average price of $63.77.

Ryan Specialty (NYSE:RYANGet Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, meeting the consensus estimate of $0.41. The firm had revenue of $604.69 million during the quarter, compared to the consensus estimate of $602.04 million. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The business’s revenue was up 20.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.32 earnings per share. Analysts predict that Ryan Specialty will post 1.8 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were given a $0.11 dividend. This represents a $0.44 annualized dividend and a dividend yield of 0.60%. The ex-dividend date was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio (DPR) is currently 57.14%.

About Ryan Specialty

(Get Free Report

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

See Also

Analyst Recommendations for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.